- Home
- MQ vs BCRX Comparison
MQ vs BCRX Comparison
Compare MQ & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- BCRX
- Stock Information
- Founded
- MQ 2010
- BCRX 1986
- Country
- MQ United States
- BCRX United States
- Employees
- MQ N/A
- BCRX N/A
- Industry
- MQ Computer Software: Prepackaged Software
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MQ Technology
- BCRX Health Care
- Exchange
- MQ Nasdaq
- BCRX Nasdaq
- Market Cap
- MQ 1.9B
- BCRX 1.9B
- IPO Year
- MQ 2021
- BCRX 1994
- Fundamental
- Price
- MQ $5.83
- BCRX $8.76
- Analyst Decision
- MQ Hold
- BCRX Strong Buy
- Analyst Count
- MQ 13
- BCRX 10
- Target Price
- MQ $5.15
- BCRX $16.70
- AVG Volume (30 Days)
- MQ 5.9M
- BCRX 3.4M
- Earning Date
- MQ 08-06-2025
- BCRX 08-04-2025
- Dividend Yield
- MQ N/A
- BCRX N/A
- EPS Growth
- MQ N/A
- BCRX N/A
- EPS
- MQ 0.11
- BCRX N/A
- Revenue
- MQ $528,100,000.00
- BCRX $503,485,000.00
- Revenue This Year
- MQ $19.30
- BCRX $38.50
- Revenue Next Year
- MQ $21.97
- BCRX $10.04
- P/E Ratio
- MQ $54.51
- BCRX N/A
- Revenue Growth
- MQ N/A
- BCRX 41.67
- 52 Week Low
- MQ $3.37
- BCRX $6.02
- 52 Week High
- MQ $6.01
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- MQ 58.45
- BCRX 37.30
- Support Level
- MQ $5.70
- BCRX $8.69
- Resistance Level
- MQ $6.01
- BCRX $9.23
- Average True Range (ATR)
- MQ 0.13
- BCRX 0.30
- MACD
- MQ -0.04
- BCRX -0.04
- Stochastic Oscillator
- MQ 42.86
- BCRX 16.30
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.